Author

Giordano Madeddu

University of Sassari - Cited by 7,174

Biography

Giordano Madeddu is currently working as a Professor. His/Her research Giordano Madeddu is serving as an editorial member and reviewer of several international reputed journals. He/She has successfully completed his Administrative responsibilities.
Title
Cited by
Year
Coronavirus disease 2019 (COVID‐19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus‐2 (SARS‐CoV‐2) Omicron variant
P Boscolo‐Rizzo, G Tirelli, P Meloni, C Hopkins, G Madeddu, A De Vito, ...International forum of allergy & rhinology 12 (10), 1273-1281, 2022202
65
2022
New onset of smell and taste loss are common findings also in patients with symptomatic COVID‐19 after complete vaccination
LA Vaira, A De Vito, JR Lechien, CM Chiesa‐Estomba, M Mayo‐Yàñez, ...The Laryngoscope 132 (2), 419-421, 2022202
35
2022
Safety and efficacy of molnupiravir in SARS‐CoV‐2‐infected patients: A real‐life experience
A De Vito, A Colpani, A Bitti, B Zauli, MC Meloni, M Fois, L Denti, S Bacciu, ...Journal of Medical Virology 94 (11), 5582-5588, 2022202
24
2022
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study
LA Vaira, A De Vito, G Deiana, C Pes, F Giovanditto, V Fiore, JR Lechien, ...European Archives of Oto-Rhino-Laryngology 279 (2), 811-816, 2022202
18
2022
Five years with dolutegravir plus lamivudine as a switch strategy: much more than a positive finding
A Ciccullo, V Borghi, A Giacomelli, MV Cossu, G Sterrantino, A Latini, ...JAIDS Journal of Acquired Immune Deficiency Syndromes 88 (3), 234-237, 2021202
11
2021
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case–control study
A De Vito, M Poliseno, A Colpani, B Zauli, MV Puci, T Santantonio, ...Current Medical Research and Opinion 38 (12), 202-2033, 2022202
9
2022
Impact of early SARS-CoV-2 antiviral therapy on disease progression
A De Vito, A Colpani, L Saderi, M Puci, B Zauli, V Fiore, M Fois, ...Viruses 15 (1), 71, 2022202
8
2022
Emerging clinical features of COVID-19 related pancreatitis: case reports and review of the literature
V Fiore, R Beretta, A De Vito, A Barac, I Maida, DD Joeseph Kelvin, C Piu, ...Frontiers in Medicine 8, 9118, 2022202
7
2022
Mood reactive disorders among COVID-19 inpatients: experience from a monocentric cohort
V Fiore, A De Vito, C Fanelli, N Geremia, E Princic, A Nivoli, I Maida, ...Medical Principles and Practice 30 (6), 535-541, 2021202
7
2021
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade
L Taramasso, P Bonfanti, E Ricci, P Maggi, G Orofino, N Squillace, ...HIV medicine 23 (1), 70-79, 2022202
6
2022
Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis
G Vidili, M Arru, G Solinas, DF Calvisi, P Meloni, A Sauchella, D Turilli, ...World Journal of Gastroenterology 28 (27), 3488, 2022202
5
2022
Effectiveness of vitamin D supplements among patients hospitalized for COVID-19: results from a Monocentric Matched-Cohort Study
V Fiore, A De Vito, P Bagella, E Princic, AA Mariani, L Denti, AG Fois, ...Healthcare 10 (), 96, 2022202
5
2022
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients.
L Saderi, V Fiore, N Geremia, E Princic, C Fanelli, AA Muredda, ...Panminerva Medica, 2022202
5
2022
Real-life impact of drug toxicity on dolutegravir tolerability: clinical practice data from a multicenter Italian cohort
A Ciccullo, G Baldin, V Borghi, F Lagi, A Latini, G d’Ettorre, L Oreni, ...Viruses 1 (1), 163, 2022202
4
2022
Quick diagnosis, staging, and treatment of HCV infection among people living in prison: Opinion expert panel
V Fiore, G De Matteis, E Pontali, A De Vito, S Panese, N Geremia, I Maida, ...Frontiers in Public Health 10, 9261, 2022202
4
2022
Reversibility of central nervous system adverse events in course of ART
L Taramasso, G Orofino, E Ricci, B Menzaghi, GV De Socio, N Squillace, ...Viruses 1 (5), 1028, 2022202
4
2022
How little do we know about HIV and STIs prevention? Results from a web-based survey among the general population
A De Vito, A Colpani, B Zauli, MC Meloni, M Fois, V Fiore, GA Pintus, ...Healthcare 10 (6), 1059, 2022202
4
2022
HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects
V Fiore, E Rastrelli, G Madeddu, R Ranieri, A De Vito, R Giuliani, ...BMC Infectious Diseases 22 (1), 601, 2022202
3
2022
Infections in lung transplanted patients: a review
M Dettori, N Riccardi, D Canetti, RM Antonello, AF Piana, A Palmieri, ...Pulmonology, 0
2
2022
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study
Causes of HIV Treatment Interruption during the Last 0 Years: A Multi-Cohort Real-Life StudyA De Vito, E Ricci, B Menzaghi, G Orofino, CV Martinelli, N Squillace, ...Viruses 15 (3), 70, 030
2
2023

Referred From: https://scholar.google.com/citations?user=mrf59ZgAAAAJ&hl=en&oi=ao

Cited by
Citations 7174
h-index 42
i10-index 139
Recommended Journals
Open Access Journals